Thebaine

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf alkaloid
opioid
gptkbp:ATCCode N02AA10
gptkbp:boilingPoint Not applicable (decomposes)
gptkbp:CASNumber 115-37-7
gptkbp:chemicalFormula C19H21NO3
gptkbp:color white
gptkbp:controlledSubstanceSchedule gptkb:Australia
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
gptkbp:density 1.24 g/cm³
gptkbp:flavor bitter
gptkbp:foundIn gptkb:Papaver_orientale
gptkb:Papaver_somniferum
gptkb:opium_poppy
gptkb:Papaver_bracteatum
gptkbp:hasInChIKey UNXHWFMMPAWVPI-UHFFFAOYSA-N
gptkbp:hasPsychoactiveEffects stimulant-like
gptkbp:hasSMILES COC1=C2C3=C(C=C1)N([C@@H]4Cc5ccc(OC)cc5[C@H]3CC4)C=C2
gptkbp:hasUNII QO4R4D9D5D
https://www.w3.org/2000/01/rdf-schema#label Thebaine
gptkbp:isNotUsedAsAnalgesic true
gptkbp:isNotUsedMedically true
gptkbp:isStructurallyRelatedTo gptkb:codeine
gptkb:morphine
gptkb:noscapine
gptkb:oripavine
papaverine
gptkbp:IUPACName gptkb:(5α,6α)-7,8-didehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan
gptkbp:legalStatus gptkb:Class_A_(UK)
gptkb:Schedule_II_(US)
gptkb:Schedule_8_(Australia)
Schedule I (Canada)
gptkbp:meltingPoint 193°C
gptkbp:molecularWeight 311.38 g/mol
gptkbp:predecessor gptkb:oxycodone
gptkb:nalbuphine
gptkb:oxymorphone
gptkb:naloxone
gptkb:buprenorphine
gptkb:etorphine
gptkb:naltrexone
hydrocodone
nalmefene
gptkbp:PubChem_CID 28315
5359
DB13598
gptkbp:solubility slightly soluble
gptkbp:toxicity true
gptkbp:usedFor pharmaceutical synthesis
gptkbp:wasFirstIsolatedBy gptkb:Pierre_Jean_Robiquet
gptkbp:wasFirstIsolatedIn 1832
gptkbp:bfsParent gptkb:Poppy
gptkb:Opiate
gptkbp:bfsLayer 5